We present in vivo tests on healthy women through our optical mammograph in preparation for a clinical validation on neoadjuvant chemotherapy monitoring, and we report preliminary data on the first patient enrolled in the study.
Optical mammography in the time domain up to 1060 nm: From tests on healthy women to initial data for monitoring neoadjuvant chemotherapy
Maffeis G.;Ferocino E.;Dalla Mora A.;Cubeddu R.;Pifferi A.;Taroni P.
2021-01-01
Abstract
We present in vivo tests on healthy women through our optical mammograph in preparation for a clinical validation on neoadjuvant chemotherapy monitoring, and we report preliminary data on the first patient enrolled in the study.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Binder1.pdf
accesso aperto
Descrizione: fulltext_free
:
Post-Print (DRAFT o Author’s Accepted Manuscript-AAM)
Dimensione
206.35 kB
Formato
Adobe PDF
|
206.35 kB | Adobe PDF | Visualizza/Apri |
|
088A5A8C-8416-4436-9A64916201E6B4BE_so3566916.pdf
Accesso riservato
Descrizione: fulltext
:
Publisher’s version
Dimensione
134.44 kB
Formato
Adobe PDF
|
134.44 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
